Milan, Italy

Francesco Piras

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Fondazione Telethon Ets, Ospedale San Raffaele S.r.l.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francesco Piras. Retrieved from https://idiyas.com/inventor/francesco-piras-74x3mrha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Francesco Piras: Innovator in Gene Therapy

Introduction

Francesco Piras is a notable inventor based in Milan, Italy. He has made significant contributions to the field of gene therapy, particularly focusing on innovative approaches to enhance treatment efficacy.

Latest Patents

Francesco holds a patent for a groundbreaking invention titled "An inhibitor of p53 activation for use in haematopoietic stem and/or progenitor cell gene therapy." This patent specifically addresses the use of an inhibitor of p53 phosphorylation, with a preference for targeting p53 Serine 15 phosphorylation. This innovation has the potential to advance therapeutic strategies in gene therapy.

Career Highlights

Throughout his career, Francesco has worked with esteemed organizations such as Ospedale San Raffaele S.r.l. and Fondazione Telethon Ets. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Francesco has collaborated with Anna Christina Kajaste-Rudnitski, enhancing the scope and impact of his research endeavors.

Conclusion

Francesco Piras is a distinguished inventor whose work in gene therapy exemplifies innovation and dedication to advancing medical science. His contributions are paving the way for future breakthroughs in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…